Stay updated with breaking news from Epigenetic Reprogramming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an
Synergistic collaboration to revolutionize age-related therapies worldwideDeal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies
Phase 1 Trial of LYL797, a ROR1-Targeted CAR T-Cell Therapy Enhanced With Genetic and Epigenetic Reprogramming, in Advanced Triple-Negative...
Day four out of five of the 10th ARDD was full of new revelations. For example we learned that that median lifespan of taurine-treated mice increased by 10 to 12%!